REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 68 filers reported holding REDHILL BIOPHARMA LTD in Q4 2020. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,000 | -75.0% | 4,600 | -39.5% | 0.00% | – |
Q3 2022 | $4,000 | 0.0% | 7,600 | +65.2% | 0.00% | – |
Q2 2022 | $4,000 | -99.7% | 4,600 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $1,372,000 | +5616.7% | 4,600 | -51.1% | 0.00% | – |
Q4 2021 | $24,000 | -78.2% | 9,400 | -61.0% | 0.00% | – |
Q3 2021 | $110,000 | +155.8% | 24,101 | +288.7% | 0.00% | – |
Q2 2021 | $43,000 | -24.6% | 6,200 | -19.5% | 0.00% | – |
Q1 2021 | $57,000 | +256.2% | 7,700 | +285.0% | 0.00% | – |
Q4 2020 | $16,000 | -56.8% | 2,000 | -45.9% | 0.00% | – |
Q3 2020 | $37,000 | +146.7% | 3,700 | +68.2% | 0.00% | – |
Q2 2020 | $15,000 | +50.0% | 2,200 | 0.0% | 0.00% | – |
Q1 2020 | $10,000 | – | 2,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 300 | $2,175 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |